Ulcosol en es it fr

Ulcosol Brand names, Ulcosol Analogs

Ulcosol Brand Names Mixture

  • No information avaliable

Ulcosol Chemical_Formula


Ulcosol RX_link


Ulcosol fda sheet

Ulcosol FDA

Ulcosol msds (material safety sheet)

Ulcosol Synthesis Reference

R. P. Pioch, U.S. Pat. 4,375,547 (1982)

Ulcosol Molecular Weight

331.46 g/mol

Ulcosol Melting Point

203 oC

Ulcosol H2O Solubility


Ulcosol State


Ulcosol LogP


Ulcosol Dosage Forms

Capsule (150, 300 mg)

Ulcosol Indication

For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.

Ulcosol Pharmacology

Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.

Ulcosol Absorption

Rapid (bioavailability of nizatidine exceeds 70%)

Ulcosol side effects and Toxicity

Oral, rat LD50: 301 mg/kg. Symptoms of overdose include cholinergic-type effects including lacrimation, salivation, emesis, miosis, and diarrhea.

Ulcosol Patient Information

Ulcosol Organisms Affected

Humans and other mammals